The FDA's lax oversight of research in developing countries can do harm to vulnerable participants
- Written by C. Michael White, Distinguished Professor and Head of the Department of Pharmacy Practice, University of Connecticut

The Research Brief is a short take about interesting academic work.
The Big Idea
The Food and Drug Administration provides less stringent oversight of overseas research trials used in deciding whether to approve a drug than those...